Overview

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
Phase:
Phase 2
Details
Lead Sponsor:
University of Tennessee